Clinical Trials Logo

Clinical Trial Summary

The facial palsy is a frequent disease with a lot of etiologies. It has variable severities with sometimes heavy functional repercussions and different recovery potentials. The proposed treatments are based on surgery, physiotherapy and botulinum toxin injections. However, when recovery is incomplete, acceptance is more difficult, with an impacted quality of life. Thanks to Motion Capture and Electromyography, a quantification of the facial mimicry is now possible with a great precision. In addition with the quantification of the facial mimicry, eye-tracking, wich is widely used in the marketing field, but it also finds medical applications including head and neck lesions and facial palsy in particular, will be used to evaluate the visio of the patients on their pathology in function of the movement quantification measured with MoCap and Electromyography. The aim of this research is to measure in a combined way the action potentials by sEMG and the amplitudes of displacement of the markers in motion capture, for movements determined in a population of patients presenting a facial pathology, in order to compare them with reference values obtained in healthy subjects. In a second step, the aim will be to study if there is a link between the way the patient looks at his pathology and the results of his management (treatment, rehabilitation) which will be quantitatively evaluated thanks to MoCap and sEMG.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05581680
Study type Interventional
Source Centre Hospitalier Universitaire, Amiens
Contact Stéphanie Dakpé, Pr
Phone 03 22 08 90 50
Email dakpe.stephanie@chu-amiens.fr
Status Recruiting
Phase N/A
Start date October 12, 2022
Completion date October 2028

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05547477 - Continuous EMG Measurements in Children With Asthma During Sleep
Completed NCT02403063 - Electromyographic Activity of the Respiratory Muscles During Neostigmine or Sugammadex Enhanced Recovery After Neuromuscular Blockade Phase 4
Completed NCT05114629 - Biomechanics of Adaptive Rowing in Active and Inactive Manual Wheelchair Users
Recruiting NCT04538807 - EMG Finding According to the Type of Lumbar Disc Herniation
Completed NCT03715777 - Electromyographic Study for the Help and Guidance of BoNTA Administration in the Treatment of Chronic Pelvic Floor Pain Phase 3
Recruiting NCT05608850 - Acute Responses of Postural Alignment, Kinematic Synergy, and Intermuscular Coherence to Postural Muscle Facilitation N/A
Not yet recruiting NCT03837886 - Effects of Sodium Bicarbonate Supplementation on Intermittent and Intense Task N/A
Completed NCT03734133 - Electromyography Evaluation of the Impacts of Different Insoles in the Activity Patterns of the Lower Limb Muscles N/A
Not yet recruiting NCT05111652 - Electromyographic Assessment of the Shoulder Stabilizing Musculature in CrossFit® Athletes
Completed NCT02974465 - Electromyographic Biofeedback and Physical Therapy in Upper Limb Hemiparesis N/A
Recruiting NCT04312529 - Analysis of Shoulder Muscle Activity During Isokinetic Evaluation of Rotators N/A
Completed NCT04472247 - Sedation Monitoring Using Frontal Electroencephalogram, Electromyogram and Hemodynamic Responses to Pain in Critical Care
Completed NCT02630576 - Neurostimulation and Electromyographs Assessment of th TetraGraph in Healthy (Volunteers N/A
Recruiting NCT03963258 - Short-Term Effects of Whole-Body Vibration on Upper Extremity Function in Subjects With Poststroke Hemiplegia N/A
Completed NCT06219876 - Comparison of the Efficacy of High Intensity Laser Therapy and Low Level Laser Therapy in the Carpal Tunnel Syndrome N/A
Recruiting NCT05965804 - Vastus Medialis Activation During McMurray's Test
Completed NCT02974452 - Age-related Changes of Shoulder Muscles N/A
Active, not recruiting NCT05281900 - Investigation of Muscular Activation Levels Around the Scapula and Shoulder in Exercises Which Body Weight is Carried N/A
Recruiting NCT04775030 - Methodology for Developing an Occlusal Appliance With CBD Active Carrier Phase 2/Phase 3
Completed NCT03994640 - Myorelaxant Effect of Cannabis Cream Topical Skin Application in Patients With TMD Phase 2/Phase 3